Evidence map›Paper›PMID 25671253›Full record

Trial reportThe New England journal of medicine2015

HIV-positive-to-HIV-positive kidney transplantation--results at 3 to 5 years.

Elmi Muller, Zunaid Barday, Marc Mendelson, Delawir Kahn

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in The New England journal of medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed, 6 pooled it
18.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 6 syntheses or guidelines pooled it, 225 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Donor heart selection: Evidence-based guidelines for providers.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2023
    Guideline
  5. Guideline
  6. Guideline
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Safety of Kidney Transplantation from Donors with HIV.The New England journal of medicine · 2024
    Observational
  16. Article
  17. An Update on Viral Infection-Associated Collapsing Glomerulopathy.Advances in kidney disease and health · 2024
    Review
  18. Review
  19. Review
  20. Review

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Elmi MullerFrom the Transplant Unit, Department of Surgery (E.M.), Division of Nephrology, Department of Medicine (Z.B.), Division of Infectious Diseases and HIV Medicine, Department of Medicine (M.M.), and the Department of Surgery (D.K.), University of Cape Town, Groote Schuur Hospital, Cape Town, South Africa.
Zunaid Barday
Marc Mendelson
Delawir Kahn
Groote Schuur Hospital · ZANHS Blood and Transplant · GB

Funding

Risk assessment of HIV infected to HIV infected transplantation in SAU01AI116061 · NIAID · UNIVERSITY OF CAPE TOWN · PI MULLER, ELMI, QUINN, THOMAS C. · 2015 to 2019
$875k
NIAID NIH HHS U01 AI116061
6 · The paper itself

Abstract

backgroundThe outcome of kidney transplantation in human immunodeficiency virus (HIV)-positive patients who receive organs from HIV-negative donors has been reported to be similar to the outcome in HIV-negative recipients. We report the outcomes at 3 to 5 years in HIV-positive patients who received kidneys from HIV-positive deceased donors.

methodsWe conducted a prospective, nonrandomized study of kidney transplantation in HIV-infected patients who had a CD4 T-cell count of 200 per cubic millimeter or higher and an undetectable plasma HIV RNA level. All the patients were receiving antiretroviral therapy (ART). The patients received kidneys from deceased donors who tested positive for HIV with the use of fourth-generation enzyme-linked immunosorbent assay at the time of referral. All the donors either had received no ART previously or had received only first-line ART.

resultsFrom September 2008 through February 2014, a total of 27 HIV-positive patients underwent kidney transplantation. Survivors were followed for a median of 2.4 years. The rate of survival among the patients was 84% at 1 year, 84% at 3 years, and 74% at 5 years. The corresponding rates of graft survival were 93%, 84%, and 84%. (If a patient died with a functioning graft, the calculation was performed as if the graft had survived.) Rejection rates were 8% at 1 year and 22% at 3 years. HIV infection remained well controlled, with undetectable virus in blood after the transplantation.

conclusionsKidney transplantation from an HIV-positive donor appears to be an additional treatment option for HIV-infected patients requiring renal-replacement therapy. (Funded by Sanofi South Africa and the Roche Organ Transplantation Research Foundation.).

Indexed as

HIV SeropositivityKidney TransplantationTissue DonorsAdultAllograftsAntibiotic ProphylaxisAnti-Retroviral AgentsCD4 Lymphocyte CountDisease ProgressionFemaleFollow-Up StudiesGraft RejectionHumansMaleMiddle AgedPostoperative ComplicationsAnti-Retroviral Agents

Identifiers

PMID25671253
PMCPMC5090019
OpenAlexW2171341849

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.